Suppr超能文献

人微粒体环氧化物水解酶:氨基酸变体的遗传多态性及体外功能表达

Human microsomal epoxide hydrolase: genetic polymorphism and functional expression in vitro of amino acid variants.

作者信息

Hassett C, Aicher L, Sidhu J S, Omiecinski C J

机构信息

Department of Environmental Health, School of Public Health and Community Medicine, University of Washington, Seattle 98195.

出版信息

Hum Mol Genet. 1994 Mar;3(3):421-8. doi: 10.1093/hmg/3.3.421.

Abstract

Human microsomal epoxide hydrolase (mEH) is a biotransformation enzyme that metabolizes reactive epoxide intermediates to more water-soluble trans-dihydrodiol derivatives. We compared protein-coding sequences from six full-length human mEH DNA clones and assessed potential amino acid variation at seven positions. The prevalence of these variants was assessed in at least 37 unrelated individuals using polymerase chain reaction experiments. Only Tyr/His 113 (exon 3) and His/Arg 139 (exon 4) variants were observed. The genotype frequencies determined for residue 113 alleles indicate that this locus may not be in Hardy-Weinberg equilibrium, whereas frequencies observed for residue 139 alleles were similar to expected values. Nucleotide sequences coding for the variant amino acids were constructed in an mEH cDNA using site-directed mutagenesis, and each was expressed in vitro by transient transfection of COS-1 cells. Epoxide hydrolase mRNA level, catalytic activity, and immunoreactive protein were evaluated for each construct. The results of these analyses demonstrated relatively uniform levels of mEH RNA expression between the constructs. mEH enzymatic activity and immunoreactive protein were strongly correlated, indicating that mEH specific activity was similar for each variant. However, marked differences were noted in the relative amounts of immunoreactive protein and enzymatic activity resulting from the amino acid substitutions. These data suggest that common human mEH amino acid polymorphisms may alter enzymatic function, possibly by modifying protein stability.

摘要

人微粒体环氧化物水解酶(mEH)是一种生物转化酶,可将具有反应活性的环氧化物中间体代谢为水溶性更高的反式二氢二醇衍生物。我们比较了六个全长人mEH DNA克隆的蛋白质编码序列,并评估了七个位置上潜在的氨基酸变异。使用聚合酶链反应实验在至少37名无关个体中评估了这些变异的发生率。仅观察到Tyr/His 113(外显子3)和His/Arg 139(外显子4)变异。对113位残基等位基因确定的基因型频率表明该位点可能不符合哈迪-温伯格平衡,而139位残基等位基因观察到的频率与预期值相似。使用定点诱变在mEH cDNA中构建编码变异氨基酸的核苷酸序列,并通过COS-1细胞的瞬时转染在体外进行表达。对每个构建体评估环氧化物水解酶mRNA水平、催化活性和免疫反应性蛋白。这些分析结果表明各构建体之间mEH RNA表达水平相对一致。mEH酶活性与免疫反应性蛋白密切相关,表明每种变异体的mEH比活性相似。然而,氨基酸取代导致的免疫反应性蛋白和酶活性的相对量存在明显差异。这些数据表明常见的人mEH氨基酸多态性可能会改变酶功能,可能是通过改变蛋白质稳定性来实现的。

相似文献

1
人微粒体环氧化物水解酶:氨基酸变体的遗传多态性及体外功能表达
Hum Mol Genet. 1994 Mar;3(3):421-8. doi: 10.1093/hmg/3.3.421.
2
Post-transcriptional regulation of human microsomal epoxide hydrolase.
Pharmacogenetics. 1998 Apr;8(2):157-67. doi: 10.1097/00008571-199804000-00008.
4
噻唑和吡嗪对大鼠肝微粒体环氧化物水解酶的诱导作用:2-氰基环氧乙烷的水解
Carcinogenesis. 1993 Aug;14(8):1665-70. doi: 10.1093/carcin/14.8.1665.
5
人类对1,3 - 丁二烯的敏感性:微粒体环氧化物水解酶多态性的作用。
Carcinogenesis. 2001 Mar;22(3):415-23. doi: 10.1093/carcin/22.3.415.
6
Rabbit microsomal epoxide hydrolase: isolation and characterization of the xenobiotic metabolizing enzyme cDNA.
Arch Biochem Biophys. 1989 Jun;271(2):380-9. doi: 10.1016/0003-9861(89)90287-7.
9
人肝微粒体环氧化物水解酶:多态性表达的比较分析。
Arch Biochem Biophys. 1997 Jan 15;337(2):275-83. doi: 10.1006/abbi.1996.9794.
10
细胞色素P-450和微粒体环氧化物水解酶在人脑组织中的区域特异性表达。
J Toxicol Environ Health. 1993 Oct-Nov;40(2-3):317-35. doi: 10.1080/15287399309531797.

引用本文的文献

1
EPHX1通过激活肝癌细胞系中的JAK/STAT信号通路增强对瑞戈非尼的耐药性。
Hereditas. 2025 Jul 31;162(1):148. doi: 10.1186/s41065-025-00517-1.
2
EPHX1和ERCC2基因多态性与泰国癌症患者顺铂诱导的肾毒性及预后相关。
PLoS One. 2025 Jun 17;20(6):e0324699. doi: 10.1371/journal.pone.0324699. eCollection 2025.
3
并且多态性与慢性阻塞性肺疾病风险相关:一项系统评价和荟萃分析。
Front Genet. 2023 May 22;14:1128985. doi: 10.3389/fgene.2023.1128985. eCollection 2023.
4
复方丹参滴丸与华法林相互作用的评估及其与环氧化物水解酶基因的临床关联
Front Pharmacol. 2023 May 4;14:1105702. doi: 10.3389/fphar.2023.1105702. eCollection 2023.
5
肝细胞癌和胆管癌的药物遗传学
Cancer Drug Resist. 2019 Sep 19;2(3):680-709. doi: 10.20517/cdr.2019.006. eCollection 2019.
7
微粒体环氧化物水解酶对心血管生物学的调节作用。
Toxicol Res. 2021 Jan 21;37(3):285-292. doi: 10.1007/s43188-021-00088-z. eCollection 2021 Jul.
9
对囊性纤维化患者的表型和结局进行全基因组测序的应用。
Cold Spring Harb Mol Case Stud. 2020 Feb 3;6(1). doi: 10.1101/mcs.a004531. Print 2020 Feb.
10
多环芳烃暴露修饰的母体EPHX1基因多态性对先天性心脏病的影响。
Medicine (Baltimore). 2019 Jul;98(30):e16556. doi: 10.1097/MD.0000000000016556.

本文引用的文献

1
人外周血淋巴细胞作为肝脏和肺微粒体环氧化物水解酶活性的指标。
Pharmacogenetics. 1993 Jun;3(3):150-8. doi: 10.1097/00008571-199306000-00005.
2
细胞色素P-450和微粒体环氧化物水解酶在人脑组织中的区域特异性表达。
J Toxicol Environ Health. 1993 Oct-Nov;40(2-3):317-35. doi: 10.1080/15287399309531797.
4
微粒体环氧化物水解酶的分子特性与生物学功能
Annu Rev Pharmacol Toxicol. 1980;20:513-31. doi: 10.1146/annurev.pa.20.040180.002501.
5
苯并(a)芘的代谢活化通过二醇环氧化物进行。
Nature. 1974 Nov 22;252(5481):326-8. doi: 10.1038/252326a0.
9
大鼠肝脏微粒体异生物质环氧化物水解酶的互补DNA及氨基酸序列
Arch Biochem Biophys. 1986 Jul;248(1):121-9. doi: 10.1016/0003-9861(86)90408-x.
10
人肝脏微粒体环氧化物水解酶的核苷酸及推导的氨基酸序列
Nucleic Acids Res. 1987 Sep 11;15(17):7188. doi: 10.1093/nar/15.17.7188.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验